Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women

Gynecol Endocrinol. 2018 Mar;34(3):223-228. doi: 10.1080/09513590.2017.1381838. Epub 2017 Sep 23.


Polycystic ovary syndrome is a complex disease characterized by various endocrine disorders that are the potential cause of anovulation and hyperandrogenism. Anti-Müllerian hormone expression is suspected to be overexpressed in PCOS granulosa cells. AMH acts as a regulator of folliculogenesis: it is produced by the granulosa cells of follicles from the stage of the primary follicle to the initial formation of the antrum. Serum and intrafollicular AMH levels are elevated in patients with PCOS due to increased number of small follicles and an increased secretion within each of these small follicles. This excess of AMH is strongly suspected to play a role in the characteristic follicular arrest of PCOS, through a negative action on aromatase expression and on FSH action. Value above 5 ng/ml or 35 pmol/l might be considered as a diagnostic criterion for PCOS. The aim of our study is to demonstrate the presence of higher AMH serum levels and higher AMH intrafollicular fluid level of PCOS patients, undergone to IVF cycles, compared to normovulatory patients. The results clearly indicate that blood and intrafollicular AMH levels are significantly higher in PCOS women comparing to the normovulatory population. Serum AMH level appears to be a good predictive marker for the risk ovarian hyperstimulation syndrome: thus, its evaluation should be recommended before starting a controlled ovarian stimulation for IVF.

Keywords: AMH; IVF; OHSS; PCOS.

MeSH terms

  • Adult
  • Anti-Mullerian Hormone / blood
  • Anti-Mullerian Hormone / metabolism*
  • Female
  • Follicular Fluid / metabolism*
  • Humans
  • Ovarian Follicle / metabolism*
  • Polycystic Ovary Syndrome / blood
  • Polycystic Ovary Syndrome / metabolism*
  • Young Adult


  • Anti-Mullerian Hormone